documents: FDA-2023-D-4177-0021

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2023-D-4177-0021 FDA FDA-2023-D-4177 Quality Considerations for Topical Ophthalmic Drug Products; Revised Draft Guidance for Industry; Availability Notice Notice of Availability 2023-12-28T05:00:00Z 2023 12 2023-12-28T05:00:00Z   2023-12-28T15:10:09Z 2023-28595 0 0 090000648636165b

Links from other tables